跳转至内容
Merck
CN

1337809

USP

亚胺培南 一水合物

United States Pharmacopeia (USP) Reference Standard

别名:

Primaxin 一水合物, Tienam 一水合物, (5R,6S)-6-[((1R)-1-羟基乙基] -3-[[2-[(亚氨基甲基)氨基]乙基]硫代] -7-氧代-1-氮杂双环[3.2.0] hept-2 -烯-2-羧酸 一水合物

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C12H17N3O4S · H2O
化学文摘社编号:
分子量:
317.36
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

亚胺培南 一水合物, United States Pharmacopeia (USP) Reference Standard

InChI

1S/C12H17N3O4S.H2O/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17;/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19);1H2/t6-,7-,9-;/m1./s1

SMILES string

O.C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O

InChI key

GSOSVVULSKVSLQ-JJVRHELESA-N

grade

pharmaceutical primary standard

API family

imipenem

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

正在寻找类似产品? 访问 产品对比指南

Biochem/physiol Actions

亚胺培南一水合物是广谱 B -内酰胺抗生素。
亚胺培南一水合物是广谱 B -内酰胺抗生素。 它是碳青霉烯类“魔弹”抗生素的一种,用于严重感染。

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Imipenem monohydrate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Imipenem
  • Imipenem and Cilastatin for Injectable Suspension
  • Imipenem and Cilastatin for Injection

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

The deadly impact of extreme drug resistance in Acinetobacter baumannii.
Brad Spellberg et al.
Critical care medicine, 42(5), 1289-1291 (2014-04-17)
Imipenem heteroresistance: high prevalence among Enterobacteriaceae Klebsiella pneumoniae carbapenemase producers.
Carolina Silva Nodari et al.
Journal of medical microbiology, 64(Pt 1), 124-126 (2014-10-30)
Hao-Yuan Lee et al.
Critical care medicine, 42(5), 1081-1088 (2014-01-08)
Acinetobacter baumannii complex bacteremia has been identified increasingly in critical patients admitted in ICUs. Notably, A. baumannii complex bacteremia has a high mortality rate, yet the risk factors associated with mortality remain unclear and controversial. Retrospective study. All adult ICUs
Anne-Laure Michon et al.
Journal of pediatric hematology/oncology, 36(3), e165-e168 (2013-05-15)
Roseomonas are described as opportunistic pathogens rarely involved in human infections. Their identification requires molecular methods and their antimicrobial susceptibility pattern varies according to the species. We report the first case of bacteremia due to Roseomonas mucosa in a child
Yi-Jiun Pan et al.
Antimicrobial agents and chemotherapy, 59(2), 1038-1047 (2014-12-03)
Klebsiella pneumoniae is an important human pathogen associated with a variety of diseases, and the prevalence of multidrug-resistant K. pneumoniae (MDRKP) is rapidly increasing. Here we determined the capsular types of 85 carbapenem-resistant K. pneumoniae (CRKP) strains by wzc sequencing

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持